Geoffrey S. Dow
President and CEO at 60 Degrees Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: 60 Degrees Pharmaceuticals Inc., 3 years.
Chief executive roles
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
65.2% a year in revenue
20% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
60 Degrees Pharmaceuticals Inc. July 16, 2024100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +7,350 | $1.38 | $10,143 |
| Dec 15, 2025 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +9,670 | $0.80 | $7,736 |
| Dec 11, 2025 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +3,613 | $0.92 | $3,324 |
| Dec 10, 2025 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +9,350 | $0.95 | $8,883 |
| Sep 12, 2025 | 60 Degrees Pharmaceuticals Inc. | Grant or award | +7,201 | $1.39 | $10,009 |
| Jun 9, 2025 | 60 Degrees Pharmaceuticals Inc. | Grant or award | +4,376 | $2.99 | $13,084 |
| Jan 17, 2025 | 60 Degrees Pharmaceuticals Inc. | Grant or award | +14,394 | — | — |
| Dec 9, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +35,823 | $1.27 | $45,495 |
| Dec 6, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +20,579 | $1.20 | $24,695 |
| Dec 5, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +17,549 | $1.11 | $19,479 |
| Nov 21, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +3,500 | $0.91 | $3,185 |
| Nov 20, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +1,000 | $0.92 | $920 |
| Nov 19, 2024 | 60 Degrees Pharmaceuticals Inc. | Open-market purchase | +2,500 | $0.90 | $2,250 |
| May 16, 2024 | 60 Degrees Pharmaceuticals Inc. | Option exercise | +17,000 | $0.22 | $3,740 |
| Apr 12, 2024 | 60 Degrees Pharmaceuticals Inc. | Option exercise | +68,000 | $0.27 | $18,360 |
Questions about Geoffrey S. Dow
What boards is Geoffrey S. Dow on?
Geoffrey S. Dow sits on the board of 60 Degrees Pharmaceuticals Inc.
What company is Geoffrey S. Dow the CEO of?
Geoffrey S. Dow has been President and CEO of 60 Degrees Pharmaceuticals Inc. since July 2023.
How long has Geoffrey S. Dow served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.